top of page



Lilly Sues Four More Over Compounded Tirzepatide and the Fallout Has Just Begun
Lilly also claims that these telehealth companies are not just selling unapproved versions of tirzepatide—they are actively shaping the pres
13 hours ago3 min read
2,631


BREAKING: Novo Nordisk Has Filed for Approval for High Dose Oral Semaglutide
Breaking news today as Novo Nordisk has aknowledged that they have applied for FDA approval for a high dose version of their oral...
2 days ago3 min read
1,168


Orforglipron: Phase 3 Data Shows Ozempic-Like Results, In Pill Form
Eli Lilly’s oral GLP-1 candidate orforglipron met all primary and secondary endpoints in a Phase 3 study of adults with type 2 diabetes, the
6 days ago2 min read
794
ON THE PEN LIVE


CONSIDERING GLP-1 MEDS?
Obesity is a complex, chronic disease that the American Medical Association recognized in 2013. Like any illness, it deserves effective medical treatment and support. Our FAQ page can help you get started, from talking to your doctor about medications like Zepbound and Wegovy to navigating insurance challenges.
DISCORD

bottom of page